226x98

EIF’s National Colorectal Cancer Research Alliance (NCCRA) is dedicated to the eradication of colorectal cancer by promoting the importance of early medical screening and funding research to develop better tests, treatments, and ultimately a cure.  The initiative was co-founded in March of 2000 by Katie Couric, Lilly Tartikoff, and EIF. Click here to make a donation.

Other Features

  • Where Does Your State Stand?

    Where Does Your State Stand?

    Dear Supporters,    When EIF’s National Colorectal Cancer... Learn More

  • Federal Cancer Research Funding At Risk

    Federal Cancer Research Funding At Risk

    Federally-funded research has contributed significantly to the progress in... Learn More

promo_donate

Donate

Make a difference by supporting EIF.

promo_volunteer

Volunteer

Lend a hand and give back to your community.

Join Us

promo_fb promo_twitter

share / bookmark page

EIF'S National Colorectal Cancer Research Alliance

Colorectal cancer is the second leading cause of cancer-related deaths in America.  Yet, this cancer is largely preventable through appropriate screening and can be cured 90% of the time when detected early.  EIF’s NCCRA is leading the national effort to raise awareness for the importance of getting screened and has awarded millions of dollars in grants to improve the way colon cancer is prevented, detected and treated.

 

Raising Awareness To Get People Screened       Highlighting Public Policy     Katie Couric on Colon Cancer Awareness

What Do we do?

EIF’s NCCRA has raised over $33 million to fund colorectal cancer research, promote colorectal cancer screening, and support gastrointestinal care.

MAKE A DONATION

Learn more about EIF's NCCRA's impact:

Encouraging Screening: EHE International, EIF's NCCRA and the CDC Join Forces
Funding Cutting-Edge ResearchImproving Patient Care

View Katie Couric's Colorectal Cancer Screening PSA on ABCnews.com.

Looking for more ways to get involved?
Get the NCCRA Tool Kit 

Join

Where does the money go?

chart

EIF’s NCCRA funding supports cutting-edge research at several leading institutions conducted by world-class scientists working on prevention, diagnostic tools, treatment, and, ultimately, a cure for colorectal cancer:

 

Dennis J. Slamon, M.D., Ph.D
Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
NCCRA Chair

With EIF seed funding, Dr. Dennis Slamon’s research at the Jonsson Cancer Center at UCLA focused on studying specific genetic alterations associated with the development and progression of colorectal cancer. By focusing on a specific area of the chromosome associated with colon cancer, called 20-q, Dr. Slamon and his team have identified ten possible candidate ...

Explore Our Programs